Duodenal Gastrointestinal Stromal Tumors (DGIST): Unresolved Discordance in the Extent of Resection and Sequencing of Therapy-Experience of Tertiary Care Hospital over 14 Years

十二指肠胃肠道间质瘤(DGIST):切除范围和治疗顺序方面仍存在未解决的分歧——一家三级医院14年的经验

阅读:1

Abstract

DGIST represents a small subset, accounting for 4-5% of all GIST. The intricacies of the duodenum's anatomy had led to a scarcity of comprehensive surgical guidelines for its management. Ours is a high-volume pancreaticobiliary unit, and we retrospectively evaluated the management and outcomes of patients with duodenal GIST to formulate an algorithm. We retrospectively analyzed the demographics, perioperative outcomes, and survival data of 25 patients who were operated for DGIST from 2008 to 2021 in the Department of Surgical Gastroenterology. Out of 25 patients, 23 patients (92%) underwent LR, whereas the other 2 patients (8%) underwent PD. The most common type of LR performed was segmental resection with reconstruction (72%). The most common location was in the second (40%, n = 10) part of the duodenum. The median tumor size of the entire cohort was 4 cm. The majority of the patients had negative surgical margin (R0) (PD, 100%; LR, 96%). The 10-year overall survival (OS) for LR and PD was 89.3% and 50% (p = 0.354), while the 10-year disease-free survival (DFS) was 89.7% and 50% (p = 0.217), respectively. A management algorithm was proposed based on our experience. DGIST is a rare entity for which the surgical algorithm is unclear. In experienced hands, morbid surgery (like Whipple's) can be avoided in most of the patients with modified duodenal resection even for large tumors with good oncological outcomes. Neoadjuvant TKI should be used whenever mandated to avoid multiorgan resections.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。